Re:Cognition Health has launched a new concussion clinic in collaboration with MYndspan, using brain-scanning technology to give brain trauma patients access to insights to help monitor and accelerate their recovery.The clinic and its sophisticated…
Continue Reading
In an industry revolutionised by advanced clinical technologies and robotics, there seems to be an increasing demand to incorporate and execute artificial intelligence (AI)-based solutions to provide high-quality, patient-centred care while streamlining back-office functions…
Continue Reading
Top News
The National Eating Disorder Association shuts down its chatbot after users report that it gave them inappropriate advice for managing eating disorders, such as advising them to diet.
The association closed its human-staffed…
Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s…
Continue Reading
Meghan Doyle (left), CEO of Partum Health, accepts the MedCity INVEST Pitch Perfect award from Arundhati Parmar (right), editor-in-chief of MedCity News, May 24.
Meghan Doyle, co-founder and CEO of Partum Health, was working at…
The healthcare sector has a reputation of being notoriously slow to adopt new technologies. However, the field doesn’t seem to be immune to the lure of artificial intelligence — including large language models (LLMs),…
Continue Reading
Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. We hope this gives…
Continue Reading
Mark Cuban Cost Plus Drug Company (MCCPDC) announced it is working with global biosimilar company Coherus Biosciences, Inc. to sell Yusimry, a biosimilar version of the top-selling drug Humira, at a discounted price. Yusimry is…
Continue Reading
Mark Cuban Cost Plus Drug Company (MCCPDC) announced it is working with Coherus Biosciences, Inc. to sell Yusimry, a biosimilar version of the top-selling drug Humira, at a discounted price. Yusimry is used to treat…
Continue Reading
As the healthcare industry strives toward precision medicine, it will be essential for care providers to gain an intimate view of a patient’s response to treatment to determine its impact on their quality of…
Continue Reading
